275 related articles for article (PubMed ID: 34489556)
21. Ribosome profiling analysis identified a KRAS-interacting microprotein that represses oncogenic signaling in hepatocellular carcinoma cells.
Xu W; Deng B; Lin P; Liu C; Li B; Huang Q; Zhou H; Yang J; Qu L
Sci China Life Sci; 2020 Apr; 63(4):529-542. PubMed ID: 31240521
[TBL] [Abstract][Full Text] [Related]
22. Intricate crosstalk between MYC and non-coding RNAs regulates hallmarks of cancer.
Swier LJYM; Dzikiewicz-Krawczyk A; Winkle M; van den Berg A; Kluiver J
Mol Oncol; 2019 Jan; 13(1):26-45. PubMed ID: 30451365
[TBL] [Abstract][Full Text] [Related]
23. LncRNA H19: A novel oncogene in multiple cancers.
Yang J; Qi M; Fei X; Wang X; Wang K
Int J Biol Sci; 2021; 17(12):3188-3208. PubMed ID: 34421359
[TBL] [Abstract][Full Text] [Related]
24. Interplay Between Long Noncoding RNAs and MicroRNAs in Cancer.
Russo F; Fiscon G; Conte F; Rizzo M; Paci P; Pellegrini M
Methods Mol Biol; 2018; 1819():75-92. PubMed ID: 30421400
[TBL] [Abstract][Full Text] [Related]
25. A novel circular RNA, circPUS7 promotes cadmium-induced transformation of human bronchial epithelial cells by regulating Kirsten rat sarcoma viral oncogene homolog expression via sponging miR-770.
Pan S; Wang Q; Zhang Q; Zhou M; Li L; Zhou X
Metallomics; 2021 Jul; 13(7):. PubMed ID: 34232319
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNA DLEU2 predicts a poor prognosis and enhances malignant properties in laryngeal squamous cell carcinoma through the miR-30c-5p/PIK3CD/Akt axis.
Li X; Xu F; Meng Q; Gong N; Teng Z; Xu R; Zhao M; Xia M
Cell Death Dis; 2020 Jun; 11(6):472. PubMed ID: 32555190
[TBL] [Abstract][Full Text] [Related]
27. Deciphering the role of KRAS gene in oncogenesis: Focus on signaling pathways, genetic alterations in 3'UTR, KRAS specific miRNAs and therapeutic interventions.
Chhichholiya Y; Singh HV; Vashistha R; Singh S; Munshi A
Crit Rev Oncol Hematol; 2024 Feb; 194():104250. PubMed ID: 38143047
[TBL] [Abstract][Full Text] [Related]
28. The Mir181ab1 cluster promotes KRAS-driven oncogenesis and progression in lung and pancreas.
Valencia K; Erice O; Kostyrko K; Hausmann S; Guruceaga E; Tathireddy A; Flores NM; Sayles LC; Lee AG; Fragoso R; Sun TQ; Vallejo A; Roman M; Entrialgo-Cadierno R; Migueliz I; Razquin N; Fortes P; Lecanda F; Lu J; Ponz-Sarvise M; Chen CZ; Mazur PK; Sweet-Cordero EA; Vicent S
J Clin Invest; 2020 Apr; 130(4):1879-1895. PubMed ID: 31874105
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-30a attenuates mutant KRAS-driven colorectal tumorigenesis via direct suppression of ME1.
Shen H; Xing C; Cui K; Li Y; Zhang J; Du R; Zhang X; Li Y
Cell Death Differ; 2017 Jul; 24(7):1253-1262. PubMed ID: 28475173
[TBL] [Abstract][Full Text] [Related]
30. miR-181a decelerates proliferation in cutaneous squamous cell carcinoma by targeting the proto-oncogene KRAS.
Neu J; Dziunycz PJ; Dzung A; Lefort K; Falke M; Denzler R; Freiberger SN; Iotzova-Weiss G; Kuzmanov A; Levesque MP; Dotto GP; Hofbauer GFL
PLoS One; 2017; 12(9):e0185028. PubMed ID: 28931048
[TBL] [Abstract][Full Text] [Related]
31. The lncRNA MALAT1 acts as a competing endogenous RNA to regulate KRAS expression by sponging miR-217 in pancreatic ductal adenocarcinoma.
Liu P; Yang H; Zhang J; Peng X; Lu Z; Tong W; Chen J
Sci Rep; 2017 Jul; 7(1):5186. PubMed ID: 28701723
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of miR‑143 modulates KRAS expression in colorectal carcinoma cells.
Liu H; Liu J; Huo J; Li K; Li K; Guo H; Yang Y
Oncol Rep; 2019 Dec; 42(6):2759-2767. PubMed ID: 31638218
[TBL] [Abstract][Full Text] [Related]
33. microRNA classifiers are powerful diagnostic/prognostic tools in ALK-, EGFR-, and KRAS-driven lung cancers.
Gasparini P; Cascione L; Landi L; Carasi S; Lovat F; Tibaldi C; Alì G; D'Incecco A; Minuti G; Chella A; Fontanini G; Fassan M; Cappuzzo F; Croce CM
Proc Natl Acad Sci U S A; 2015 Dec; 112(48):14924-9. PubMed ID: 26627242
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA-425-5p Expression Affects BRAF/RAS/MAPK Pathways In Colorectal Cancers.
Angius A; Pira G; Scanu AM; Uva P; Sotgiu G; Saderi L; Manca A; Serra C; Uleri E; Piu C; Caocci M; Ibba G; Zinellu A; Cesaraccio MR; Sanges F; Muroni MR; Dolei A; Cossu-Rocca P; De Miglio MR
Int J Med Sci; 2019; 16(11):1480-1491. PubMed ID: 31673240
[TBL] [Abstract][Full Text] [Related]
35. Noncoding RNAs: New Players in Cancers.
Chen X; Fan S; Song E
Adv Exp Med Biol; 2016; 927():1-47. PubMed ID: 27376730
[TBL] [Abstract][Full Text] [Related]
36. Long non-coding RNAs: an overview on miRNA sponging and its co-regulation in lung cancer.
Rajakumar S; Jamespaulraj S; Shah Y; Kejamurthy P; Jaganathan MK; Mahalingam G; Ramya Devi KT
Mol Biol Rep; 2023 Feb; 50(2):1727-1741. PubMed ID: 36441373
[TBL] [Abstract][Full Text] [Related]
37. LINC00467: A key oncogenic long non-coding RNA.
Changizian M; Nourisanami F; Hajpoor V; Parvaresh M; Bahri Z; Motovali-Bashi M
Clin Chim Acta; 2022 Nov; 536():112-125. PubMed ID: 36122666
[TBL] [Abstract][Full Text] [Related]
38. The function of LncRNA-ATB in cancer.
Anbiyaiee A; Ramazii M; Bajestani SS; Meybodi SM; Keivan M; Khoshnam SE; Farzaneh M
Clin Transl Oncol; 2023 Jan; 25(1):1-9. PubMed ID: 35597865
[TBL] [Abstract][Full Text] [Related]
39. LncRNA BCYRN1 inhibits glioma tumorigenesis by competitively binding with miR-619-5p to regulate CUEDC2 expression and the PTEN/AKT/p21 pathway.
Mu M; Niu W; Zhang X; Hu S; Niu C
Oncogene; 2020 Nov; 39(45):6879-6892. PubMed ID: 32978519
[TBL] [Abstract][Full Text] [Related]
40. Functional roles of long noncoding RNA MALAT1 in gynecologic cancers.
Farzaneh M; Najafi S; Dari MAG; Sheykhi-Sabzehpoush M; Dayer D; Cheraghzadeh M; Azizidoost S
Clin Transl Oncol; 2023 Jan; 25(1):48-65. PubMed ID: 36042115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
